Table 1 IL-6 and IL-8 ascites levels in relation to different clinicopathological parameters
From: Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients
| Â | No of ascites tested (%) | IL-6 mean pg/ml (SEM) | IL-8 mean pg/ml (SEM) |
|---|---|---|---|
Total | 39 | 6419 (1409) | 1408 (437) |
Stage | Â | Â | Â |
I | 9 (23) | 4526 (3081) | 1447 (997) |
II | 4 (10) | 8893 (4719) | 2738 (1786) |
III | 15 (39) | 6550 (2521) | 1181 (685) |
IV | 11 (28) | 6514 (1869) | 1119 (607) |
Histopathology | Â | Â | Â |
Serous | 26 (67) | 5209 (1484) | 801 (339) |
Mucinous | 3 (8) | 12641 (7227) | 3375 (2596) |
Mixed | 7 (18) | 8916 (4084) | 2991 (1500) |
Endometrioid | 1 (2) | 7896 (0) | 463(0) |
Other | 2 (5) | 1277 (583) | 1268 (590) |
Grading a | Â | Â | Â |
1 | 4 (10) | 3102 (1625) | 228 (82) |
2 | 10 (27) | 8482 (3181) | 842 (538) |
3 | 20 (51) | 5831 (1739) | 1755 (661) |
Residual tumor a | Â | Â | Â |
≤ 2 cm | 34 (87) | 6286 (1487) | 1555 (495) |
> 2 cm | 4 (10) | 7457 (731) | 378 (155) |
Prior chemotherapy a | Â | Â | Â |
Yes | 4 (10) | 444 (111) | 430 (123) |
No | 34 (87) | 6984 (1453)b | 1972 (681)b |
Serum CA125 a | Â | Â | Â |
< 319 | 19 (49) | 4063 (1841) | 1372 (806) |
> 319 | 19 (49) | 4406 (1765) | 1491 (788) |